Glanis Life Sciences Private Limited

Pharmaceutical company manufacturing medicines, drugs, and formulations since 2010 in Hyderabad.

2010 | Hyderabad, Telangana (India) | Inactive
Last Updated: May 04, 2024

Glanis Life Sciences Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth %
  • Profit Growth 7.10%
  • Ebitda -75.22%
  • Net Worth -1.55%
  • Total Assets -0.05%

About Glanis Life Sciences

Glanis Life Sciences Private Limited (GLSPL) is Strike Off company established on 31 May 2010 with its office registered at Hyderabad, Telangana, India and has been running since 14 Year, 8 Months with a paid up capital of 0.10 M. According to MCA records, 3 Directors are linked to this company as of 04 May 2024.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232TG2010PTC068681

  • Company No.

    068681

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    31 May 2010

  • Date of AGM

    31 Dec 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Glanis Life Sciences?

Board Members (3)

Name Designation Appointment Date Status
Sridhar Vootla Country flag representing In Director 16-Jan-2013 Current
Sri Kondru Country flag representing In Director 28-Sep-2012 Current
Kudaravalli Sridhar Country flag representing In Director 16-Jan-2013 Current

Financial Performance of Glanis Life Sciences.

Glanis Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.1% increase in profit. The company's net worth dipped by a decrease of 1.55%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.05%
Profit or Loss
7.10%
Net Worth
-1.55%
EBITDA
-75.22%

What is the Ownership and Shareholding Structure of Glanis Life Sciences?

In 2018, Glanis Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Glanis Life Sciences?

Unlock and access historical data on people associated with Glanis Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glanis Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glanis Life Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Glanis Life Sciences

Recent activity within the organization

  • Annual General Meeting

    Glanis Life Sciences Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.

    31 Dec 2020

  • Balance Sheet

    Glanis Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.

    31 Mar 2020

  • Director Appointment

    Sridhar Vootla was appointed as a Director was appointed as a Director on 16 Jan 2013 & has been associated with this company since 12 years 22 days .

    16 Jan 2013

  • Director Appointment

    Kudaravalli Sridhar was appointed as a Director was appointed as a Director on 16 Jan 2013 & has been associated with this company since 12 years 22 days .

    16 Jan 2013

  • Director Appointment

    Sri Lakshmi Kondru was appointed as a Director was appointed as a Director on 28 Sep 2012 & has been associated with this company since 12 years 4 months .

    28 Sep 2012

  • Company Incorporation

    Glanis Life Sciences Private Limited was registered on 31 May 2010 with Roc Hyderabad & aged 14 years 8 months as per MCA records.

    31 May 2010

Frequently asked questions

  • Glanis Life Sciences Private Limited was incorporated on 31 May 2010.

  • The authorized share capital of Glanis Life Sciences Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Glanis Life Sciences Private Limited.

    • Sridhar Vootla
    • Sri Lakshmi Kondru
    • Kudaravalli Sridhar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Glanis Life Sciences Private Limited is Plot No. 406A H. 622 Road 18, Jubilee Hills India, Hyderabad, Telangana, 500033.

  • The corporate identification number (CIN) of Glanis Life Sciences Private Limited is U24232TG2010PTC068681 and the company number is 068681 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2020 indicates that The net worth of Glanis Life Sciences Private Limited has experienced an downturn of -1.55%.

  • The most recent Balance Sheet for Glanis Life Sciences Private Limited was filed with the ROC on 31 Mar 2020.

People also Viewed

Similar Companies Based on Drug Formulation & Development